-Galactosidase-cleavable linkers are a special class of chemically designed linker structures that can be cleaved under the action of a specific enzyme-galactosidasethus triggering the precise release of drugs from the drug carrier
(2024) 103:e37114
We prescribe them clinically never speculatively
Comprehensive strategies are actively being explored, including rational combinations with chemotherapy and immunomodulators, as well as for targeted nanotechnology delivery to reprogram the immune environment
Clinical trials have shown their potential in the treatment of idiopathic pulmonary fibrosis (IPF, 2018), 32 Alzheimers disease (AD, 2023, 2024, 2025), 33,34,35 diabetic macular edema (DME, 2024), 35 etc
After menopause, progesterone level drops sharply, with limited production continuing in peripheral tissues like adrenal glands